NCT06717360View on ClinicalTrials.gov

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Hypercholesterolemia
Interventions
DRUG

AG2304T

AG2304T, QD, PO

DRUG

AG2304R

AG2304R, QD, PO

Sponsors
All Listed Sponsors
lead

Ahn-Gook Pharmaceuticals Co.,Ltd

INDUSTRY

NCT06717360 - A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R | Biotech Hunter | Biotech Hunter